Insider Trading Alert - OFIX, TWO And CPTA Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, May 22, 2015, 89 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,297.00 to $237,892,500.00.

Highlighted Stocks Traded by Insiders:

Orthofix International (OFIX) - FREE Research Report

Scoon Davey, who is Director at Orthofix International, sold 5,709 shares at $32.38 on May 22, 2015. Following this transaction, the Director owned 10,917 shares meaning that the stake was reduced by 34.34% with the 5,709-share transaction.

Hinrichs James F., who is Director at Orthofix International, bought 10,000 shares at $33.17 on May 22, 2015. Following this transaction, the Director owned 16,500 shares meaning that the stake was boosted by 153.85% with the 10,000-share transaction.

The shares most recently traded at $34.17, up $1.00, or 2.93% since the insider transaction. Historical insider transactions for Orthofix International go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 5,709
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 5,709
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 5,709

The average volume for Orthofix International has been 107,300 shares per day over the past 30 days. Orthofix International has a market cap of $636.5 million and is part of the health care sector and health services industry. Shares are up 12.84% year-to-date as of the close of trading on Friday.

Orthofix International N.V., a medical device company, provides reconstructive and regenerative orthopedic and spine solutions to physicians. It operates through four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. Currently, there are 2 analysts who rate Orthofix International a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OFIX - FREE

TheStreet Quant Ratings rates Orthofix International as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and increase in stock price during the past year. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive. Get the full Orthofix International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Two Harbors Investment (TWO) - FREE Research Report

Siering Thomas, who is CEO & President at Two Harbors Investment, bought 3,000 shares at $10.69 on May 22, 2015. Following this transaction, the CEO & President owned 1.1 million shares meaning that the stake was boosted by 0.27% with the 3,000-share transaction.

The shares most recently traded at $10.64, down $0.05, or 0.47% since the insider transaction. Historical insider transactions for Two Harbors Investment go as follows:

  • 4-Week # shares bought: 3,000
  • 4-Week # shares sold: 37,969
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 37,969
  • 24-Week # shares bought: 8,000
  • 24-Week # shares sold: 83,629

The average volume for Two Harbors Investment has been 2.9 million shares per day over the past 30 days. Two Harbors Investment has a market cap of $3.9 billion and is part of the financial sector and real estate industry. Shares are up 6.39% year-to-date as of the close of trading on Friday.

Two Harbors Investment Corp. The stock currently has a dividend yield of 9.76%. The company has a P/E ratio of 13.3. Currently, there are 10 analysts who rate Two Harbors Investment a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on TWO - FREE

TheStreet Quant Ratings rates Two Harbors Investment as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, attractive valuation levels and expanding profit margins. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Two Harbors Investment Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Capitala Finance (CPTA) - FREE Research Report

Carroll Larry W., who is Director at Capitala Finance, bought 1,050 shares at $17.00 on May 22, 2015. Following this transaction, the Director owned 51,050 shares meaning that the stake was boosted by 2.1% with the 1,050-share transaction.

The shares most recently traded at $17.31, up $0.31, or 1.79% since the insider transaction. Historical insider transactions for Capitala Finance go as follows:

  • 4-Week # shares bought: 6,185
  • 12-Week # shares bought: 8,685
  • 24-Week # shares bought: 15,785

The average volume for Capitala Finance has been 117,500 shares per day over the past 30 days. Capitala Finance has a market cap of $285.2 million and is part of the financial sector and financial services industry. Shares are down 3.13% year-to-date as of the close of trading on Friday.

Capitala Finance Corp. is a Business Development Company specializing in investments in traditional mezzanine, senior subordinated and unitranche debt, second-lien loans, equity securities issued by lower and traditional middle-market companies, and small and middle-market companies. The stock currently has a dividend yield of 10.86%. The company has a P/E ratio of 15.5. Currently, there are 9 analysts who rate Capitala Finance a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CPTA - FREE

TheStreet Quant Ratings rates Capitala Finance as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and notable return on equity. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, weak operating cash flow and a generally disappointing performance in the stock itself. Get the full Capitala Finance Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

6 Stocks Trading Up With Unusual Volume

6 Stocks Trading Up With Unusual Volume

6 Stocks Trending Up With Major Volume

6 Stocks Trending Up With Major Volume

Strong And Under The Radar: Orthofix International (OFIX)

Strong And Under The Radar: Orthofix International (OFIX)

Where Will a Healthy Zimmer Biomet Turn Next for Acquisitions?

Where Will a Healthy Zimmer Biomet Turn Next for Acquisitions?

Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination

Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination